PATH is looking for a Market Access Officer

27 Jan 2020
Photo: Schumann/MMV

The VivAccess project is a Bill & Melinda Gates Foundation-funded 5-year initiative led by PATH and Medicines for Malaria Venture (MMV) to support countries in the control and elimination of Plasmodium vivax (P. vivax) malaria. The goal of VivAccess is to support the adoption and increased access to a suite of products to address the unique challenges associated with P. vivax malaria globally. Through VivAccess, PATH and MMV work closely with the World Health Organization, National Malaria Control Programs (NMCP), and country-based healthcare partners to support the introduction and use of these effective tools, which include malaria diagnostics, G6PD diagnostics, blood-stage drugs, and liver-stage radical-cure drugs. Guided by the leadership of national health agencies, VivAccess provides support in terms of market analytics, technical expertise, and product delivery coordination as countries seek to introduce effective radical cure into national malaria protocols and accelerate progress towards their malaria elimination goals.

PATH is seeking a Market Dynamics Officer to lead PATH VivAccess activities in Latin America and serve as co-Regional Advisor with a counterpart at MMV. This role will represent PATH and VivAccess in Latin America and will collaborate with NMCPs, Pan-American Health Organization (PAHO), regulatory bodies, procurement agencies, researchers and other critical national stakeholders to ensure the safe and efficient adoption of new tools for malaria. Primary focus countries include: Brazil, Colombia, and Peru, with the potential for expanded engagement over time. This position will report to the Senior Market Dynamics Officer, Malaria Portfolio Lead in Seattle.

To learn more about the role, visit the dedicated page.